BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 10198196)

  • 1. Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing.
    Hao J; Ju H; Zhao S; Junaid A; Scammell-La Fleur T; Dixon IM
    J Mol Cell Cardiol; 1999 Mar; 31(3):667-78. PubMed ID: 10198196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased Smad 7 expression contributes to cardiac fibrosis in the infarcted rat heart.
    Wang B; Hao J; Jones SC; Yee MS; Roth JC; Dixon IM
    Am J Physiol Heart Circ Physiol; 2002 May; 282(5):H1685-96. PubMed ID: 11959632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
    Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
    Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrogen sulfide alleviates myocardial collagen remodeling in association with inhibition of TGF-β/Smad signaling pathway in spontaneously hypertensive rats.
    Sun L; Jin H; Sun L; Chen S; Huang Y; Liu J; Li Z; Zhao M; Sun Y; Tang C; Zhao B; Du J
    Mol Med; 2015 Jan; 20(1):503-15. PubMed ID: 25222913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble transforming growth factor-beta1 receptor II might inhibit transforming growth factor-beta-induced myofibroblast differentiation and improve ischemic cardiac function after myocardial infarction in rats.
    Lian R; Chen Y; Xu Z; Zhang X
    Coron Artery Dis; 2010 Sep; 21(6):369-77. PubMed ID: 20613497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
    Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
    Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased myocardial collagen content in transgenic rats overexpressing cardiac angiotensin-converting enzyme is related to enhanced breakdown of N-acetyl-Ser-Asp-Lys-Pro and increased phosphorylation of Smad2/3.
    Pokharel S; van Geel PP; Sharma UC; Cleutjens JP; Bohnemeier H; Tian XL; Schunkert H; Crijns HJ; Paul M; Pinto YM
    Circulation; 2004 Nov; 110(19):3129-35. PubMed ID: 15520311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infiltrated cardiac lipids impair myofibroblast-induced healing of the myocardial scar post-myocardial infarction.
    Vilahur G; Casani L; Juan-Babot O; Guerra JM; Badimon L
    Atherosclerosis; 2012 Oct; 224(2):368-76. PubMed ID: 22882904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts.
    Chin GS; Liu W; Peled Z; Lee TY; Steinbrech DS; Hsu M; Longaker MT
    Plast Reconstr Surg; 2001 Aug; 108(2):423-9. PubMed ID: 11496185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
    Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
    Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
    Poncelet AC; de Caestecker MP; Schnaper HW
    Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of TGF-beta isoforms, TGF-beta receptors, and SMAD molecules at different stages of human glioma.
    Kjellman C; Olofsson SP; Hansson O; Von Schantz T; Lindvall M; Nilsson I; Salford LG; Sjögren HO; Widegren B
    Int J Cancer; 2000 May; 89(3):251-8. PubMed ID: 10861501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
    Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
    EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of TGF-beta, the TGF-beta type I receptor and the R-II receptor in peripheral nerves and mechanoreceptors; observations on changes after traumatic injury.
    Stark B; Carlstedt T; Risling M
    Brain Res; 2001 Sep; 913(1):47-56. PubMed ID: 11532246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Gq alpha and PLC-beta in scar and border tissue in heart failure due to myocardial infarction.
    Ju H; Zhao S; Tappia PS; Panagia V; Dixon IM
    Circulation; 1998 Mar; 97(9):892-9. PubMed ID: 9521338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of responsiveness to TGF-beta1 in a thyroid carcinoma cell line with functional type I and type II TGF-beta receptors and Smad proteins, suggests a novel mechanism for TGF-beta insensitivity in carcinoma cells.
    Heldin NE; Bergström D; Hermansson A; Bergenstråhle A; Nakao A; Westermark B; ten Dijke P
    Mol Cell Endocrinol; 1999 Jul; 153(1-2):79-90. PubMed ID: 10459856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing the role of homomeric and heteromeric receptor interactions in TGF-beta signaling using small molecule dimerizers.
    Stockwell BR; Schreiber SL
    Curr Biol; 1998 Jun; 8(13):761-70. PubMed ID: 9651680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between angiotensin II and Smad proteins in fibroblasts in failing heart and in vitro.
    Hao J; Wang B; Jones SC; Jassal DS; Dixon IM
    Am J Physiol Heart Circ Physiol; 2000 Dec; 279(6):H3020-30. PubMed ID: 11087260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted inhibition of activin receptor-like kinase 5 signaling attenuates cardiac dysfunction following myocardial infarction.
    Tan SM; Zhang Y; Connelly KA; Gilbert RE; Kelly DJ
    Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1415-25. PubMed ID: 20154262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.